Table 1.
Clinical details and tumour staging (n = 43)
| Clinical details | Pre‐op Dx (N = 36) | Post‐op Dx (N = 7) | P | |
|---|---|---|---|---|
| Mean age in years (SD) | 57.3 (17.6) | 58.5 (17.6) | 46 (24.7) | 0.4 |
| Female, n (%) | 24 (55.8) | 21 (87.5) | 3 (12.5) | 0.7 |
| Sporadic cases, n (%) | 36 (83.7) | 29 (80.5) | 7 (19.4) | |
| RET germline mutation positive, n (%) | 4 (9.3) | 4 | ‐ | |
| Family history of non‐medullary thyroid malignancy, n (%) | 3 (7.0) | 1 (33.3) | 2 (66.7) | |
| Median maximal tumour size in mm (IQR) | 25 (15–47) | 35 (13–60) | 20 (17–35) | 0.3 |
| Tumour stage, n (%) | ||||
| Tx* | 6 (14.0) | 6 (14.0) | – | |
| T1a | 4 (9.3) | 3 (75) | 1 (25) | |
| T1b | 10 (23.3) | 7 (70) | 3 (30) | |
| T2 | 9 (20.9) | 6 (67) | 3 (33) | |
| T3a | 10 (23.3) | 10 | – | |
| T3b | 1 (2.3) | 1 | – | |
| T4a | 2 (4.7) | 2 | – | |
| T4b | 0 | – | – | |
| Nodal stage, n (%) | ||||
| N0 | 19 (44.2) | 12 (63) | 7 (37) | |
| N1a | 6 (14.0) | 6 | – | |
| N1b | 17 (39.5) | 17 | – | |
| Metastasis, n (%) | ||||
| M0 | 38 (88.4) | 31 (82) | 7 (8) | |
| M1 | 4 (9.3) | 4 | – | |
| TM Stage, n (%) | ||||
| I | 9 (20.9) | 5 (56) | 4 (44) | 0.01 |
| II | 10 (23.3) | 7 (70) | 3 (30) | |
| III | 6 (14.0) | 6 | – | |
| IVa | 15 (34.9) | 15 | – | |
| IVb | 1 (2.3) | 1 | – | |
| IVc | 1 (2.3) | 1 | – | |
| Could not be staged* | 1 (2.3) | 1 | – |
Abbreviations: SD, standard deviation; IQR, interquartile range.
*
Unable to determine due to missing data.